Health
Orally administered experimental drug halts SARS-CoV-2 replication, prevents infection – News-Medical.Net
Publishing their work in Nature, scientists at the UNC School of Medicine and UNC Gillings School of Global Public Health found that the orally administered experimental…

Publishing their work in Nature, scientists at the UNC School of Medicine and UNC Gillings School of Global Public Health found that the orally administered experimental drug EIDD-2801 halts SARS-CoV-2 replication and prevents infection of human cells in a new in vivo lab model containing human lung tissue.
Separate phase 2 and 3 clinical trials are ongoing to evaluate EIDD-2801 safety in humans and its effect on viral shedding in COVID-19 patients.
The number of new COVID-19 cases continues to…
-
Noosa News15 hours ago
Help to make recycling stick
-
Noosa News21 hours ago
New South Wales Blues left to pick up the pieces after fumbling a chance at State of Origin glory
-
Noosa News24 hours ago
How do you choose a safe childcare centre?
-
Noosa News13 hours ago
Former Darling Downs Zoo employee sheds new light on horrific lion attack on teacher Joanne Cabban